CAS No. |
1595275-61-8 |
中文名称 |
[(11S,11aS)-4-[[(S)-2-[[(S)-2-氨基-3-甲基丁酰基]氨基]丙酰基]氨基]苄基](11-羟基-7-甲氧基-8-[[5-[[(S)-7-甲氧基-2-甲基-5-氧代-5,11a-二氢-1H-苯并[e]吡咯并[1,2-a][1,4]二氮杂䓬-8-基]氧基]戊基]氧基]-2-甲基-5-氧代-11,11a-二氢-1H-苯并[e]吡咯并[1,2-a][1,4]二氮杂䓬-10(5H)-羧酸酯) |
英文名称 |
(11S,11aS)-4-((S)-2-((S)-2-Amino-3-methylbutanamido)propanamido)benzyl 11-hydroxy-7-methoxy-8-((5-(((S)-7-methoxy-2-methyl-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)pentyl)oxy)-2-methyl-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate |
别名 |
L-Alaninamide, L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]carbonyl]oxy]methyl]phenyl]-;VA-PAB-SG3199;SG3199-PAB-Ala-Val-NH?;SG3199-Val-Ala-PAB;L-Alaninamide, L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5 |
标准英文名 |
4-((S)-2-((S)-2-amino-3-methylbutanamido)propanamido)benzyl (11S,11aS)-11-hydroxy-7-methoxy-8-((5-(((S)-7-methoxy-2-methyl-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)pentyl)oxy)-2-methyl-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate |
分子式 |
C49H59N7O11 |
分子量 |
922.05
|
精确分子量 |
921.43
|
SMILES |
C(OCC1=CC=C(NC([C@@H](NC([C@H](C(C)C)N)=O)C)=O)C=C1)(=O)N2C=3C(C(=O)N4[C@]([C@@H]2O)(CC(C)=C4)[H])=CC(OC)=C(OCCCCCOC5=C(OC)C=C6C(=C5)N=C[C@]7(N(C6=O)C=C(C)C7)[H])C3 |
标准SMILES |
CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NC1=CC=C(COC(=O)N2[C@@H](O)[C@@H]3CC(C)=CN3C(=O)C3=CC(OC)=C(C=C23)OCCCCCOC2C=C3N=C[C@@H]4CC(C)=CN4C(=O)C3=CC=2OC)C=C1 |
用途 |
SG3199-Val-Ala-PAB is an intermediate in the synthesis of Tesirine, which is a cytotoxic payload-linker conjugate used in antibody-drug conjugates (ADCs) for the research and treatment of various cancers. |
InChIKey |
UTSDPVVCKWJDSI-XSNNZHSXSA-N |